AMG-407

( DrugBank: - / KEGG DRUG: - )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
56	ベーチェット病	3

告示番号	疾患名（ページ内リンク）	臨床試験数
107	若年性特発性関節炎	6

56. ベーチェット病

臨床試験数 : 81 / 薬物数 : 107 - (DrugBank : 30) / 標的遺伝子数 : 36 - 標的パスウェイ数 : 116

trials per page:

Showing 1 to 3 of 3 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2019-002787-27-GR (EUCTR)	20/05/2021	07/05/2021	Apremilast study in children with active oral ulcers associated with Behçet’s Disease	A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study, Followed ...	Subjects with active Behçet’s Disease MedDRA version: 21.1;Level: LLT;Classification code 10004212;T ...	Trade Name: Otezla Product Name: Apremilast 10 mg Product Code: AMG-407 INN or Proposed INN: Apremilast ...	Amgen Inc.	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	60	Phase 3	France;Greece;Israel;Netherlands;Switzerland
2	EUCTR2019-002787-27-FR (EUCTR)		18/12/2020	Apremilast study in children with active oral ulcers associated with Behçet’s Disease	A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study, Followed ...	Subjects with active Behçet’s Disease MedDRA version: 21.1;Level: LLT;Classification code 10004212;T ...	Trade Name: Otezla Product Name: Apremilast 10 mg Product Code: AMG-407 INN or Proposed INN: Apremilast ...	Amgen Inc.	NULL	NA	Female: yes Male: yes	60	Phase 3	France;Israel;Netherlands;Switzerland
3	EUCTR2019-002787-27-NL (EUCTR)		11/02/2021	Apremilast study in children with active oral ulcers associated with Behçet’s Disease	A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study, Followed ...	Subjects with active Behçet’s Disease MedDRA version: 21.1;Level: LLT;Classification code 10004212;T ...	Trade Name: Otezla Product Name: Apremilast 10 mg Product Code: AMG-407 INN or Proposed INN: Apremilast ...	Amgen Inc.	NULL	NA	Female: yes Male: yes	60	Phase 3	France;Greece;Spain;Israel;Netherlands;United Kingdom;Switzerland;Italy

First Previous1Next Last

107. 若年性特発性関節炎

臨床試験数 : 447 / 薬物数 : 297 - (DrugBank : 57) / 標的遺伝子数 : 52 - 標的パスウェイ数 : 146

trials per page:

Showing 1 to 6 of 6 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2019-002788-88-GR (EUCTR)	14/04/2022	01/02/2022	Apremilast Study in Children with Active Juvenile Psoriatic Arthritis	A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Evalua ...	Juvenile psoriatic arthritis MedDRA version: 20.0;Level: LLT;Classification code 10079454;Term: Syst ...	Trade Name: Otezla Product Name: Apremilast 10 mg Product Code: AMG-407 INN or Proposed INN: Apremilast ...	Amgen Inc.	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	60	Phase 3	France;Greece;Poland;Belgium;Austria;Netherlands;Italy
2	EUCTR2019-002788-88-NL (EUCTR)	23/09/2021	18/02/2021	Apremilast Study in Children with Active Juvenile Psoriatic Arthritis	A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Evalua ...	Juvenile psoriatic arthritis MedDRA version: 20.0;Level: LLT;Classification code 10079454;Term: Syst ...	Trade Name: Otezla Product Name: Apremilast 10 mg Product Code: AMG-407 INN or Proposed INN: Apremilast ...	Amgen Inc.	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	60	Phase 3	France;Belgium;Austria;Netherlands;Italy
3	EUCTR2019-002788-88-FR (EUCTR)	15/04/2021	18/12/2020	Apremilast Study in Children with Active Juvenile Psoriatic Arthritis	A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Evalua ...	Juvenile psoriatic arthritis MedDRA version: 20.0;Level: LLT;Classification code 10079454;Term: Syst ...	Trade Name: Otezla Product Name: Apremilast 10 mg Product Code: AMG-407 INN or Proposed INN: Apremilast ...	Amgen Inc.	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	60	Phase 3	France;Belgium;Austria;Netherlands
4	EUCTR2019-002788-88-AT (EUCTR)	11/01/2021	05/11/2020	Apremilast Study in Children with Active Juvenile Psoriatic Arthritis	A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Evalua ...	Juvenile psoriatic arthritis MedDRA version: 20.0;Level: LLT;Classification code 10079454;Term: Syst ...	Trade Name: Otezla Product Name: Apremilast 10 mg Product Code: AMG-407 INN or Proposed INN: Apremilast ...	Amgen Inc.	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	60	Phase 3	France;Greece;Poland;Belgium;Austria;Netherlands;Italy
5	EUCTR2019-002788-88-BE (EUCTR)		15/12/2020	Apremilast Study in Children with Active Juvenile Psoriatic Arthritis	A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Evalua ...	Juvenile psoriatic arthritis MedDRA version: 20.0;Level: LLT;Classification code 10079454;Term: Syst ...	Trade Name: Otezla Product Name: Apremilast 10 mg Product Code: AMG-407 INN or Proposed INN: Apremilast ...	Amgen Inc.	NULL	NA	Female: yes Male: yes	60	Phase 3	Belgium;Austria;Netherlands
6	EUCTR2019-002788-88-PL (EUCTR)		28/01/2022	Apremilast Study in Children with Active Juvenile Psoriatic Arthritis	A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Evalua ...	Juvenile psoriatic arthritis MedDRA version: 20.0;Level: LLT;Classification code 10079454;Term: Syst ...	Trade Name: Otezla Product Name: Apremilast 10 mg Product Code: AMG-407 INN or Proposed INN: Apremilast ...	Amgen Inc.	NULL	NA	Female: yes Male: yes	60	Phase 3	France;Belgium;Poland;Austria;Netherlands;Italy

First Previous1Next Last